Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-09-27
DOI
10.1093/ibd/izz213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Origin, Differentiation, and Function of Intestinal Macrophages
- (2018) Calum C. Bain et al. Frontiers in Immunology
- Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
- (2017) Julian Panés et al. GUT
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
- (2016) Silvio Danese et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
- (2016) Laurent Peyrin-Biroulet et al. Clinical Gastroenterology and Hepatology
- Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity
- (2016) Jan Däbritz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Direct and Indirect Effects of Tofacitinib on Treatment Satisfaction in Patients with Ulcerative Colitis
- (2016) Julian Panés et al. Journal of Crohns & Colitis
- Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors
- (2015) W Gao et al. ANNALS OF THE RHEUMATIC DISEASES
- Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
- (2015) Julián Panés et al. BMC GASTROENTEROLOGY
- Reprogramming of Monocytes by GM-CSF Contributes to Regulatory Immune Functions during Intestinal Inflammation
- (2015) Jan Däbritz et al. JOURNAL OF IMMUNOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. Arthritis & Rheumatology
- The Risk of Colorectal Cancer in Patients with Ulcerative Colitis
- (2014) Tobias M. Nowacki et al. DIGESTIVE DISEASES AND SCIENCES
- IFN- -Induced TNF- Expression Is Regulated by Interferon Regulatory Factors 1 and 8 in Mouse Macrophages
- (2014) V. Vila-del Sol et al. JOURNAL OF IMMUNOLOGY
- Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
- (2014) J. Wollenhaupt et al. JOURNAL OF RHEUMATOLOGY
- Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice
- (2014) Calum C Bain et al. NATURE IMMUNOLOGY
- The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells
- (2013) Satoshi Kubo et al. ANNALS OF THE RHEUMATIC DISEASES
- A Fusion Cytokine Coupling GMCSF to IL9 Induces Heterologous Receptor Clustering and STAT1 Hyperactivation through JAK2 Promiscuity
- (2013) Pingxin Li et al. PLoS One
- Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy
- (2012) L. van de Laar et al. BLOOD
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: remission rates achievable by current therapies for inflammatory bowel disease
- (2011) L. Peyrin-Biroulet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
- (2011) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Does Anti-TNF Therapy Reduce the Requirement for Surgery in Ulcerative Colitis? A Systematic Review
- (2011) Jerome Filippi et al. CURRENT DRUG TARGETS
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis
- (2010) Vivianne Bergeron et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
- (2010) Debra M Meyer et al. Journal of Inflammation-London
- Development of Monocytes, Macrophages, and Dendritic Cells
- (2010) F. Geissmann et al. SCIENCE
- Treating inflammation with the Janus Kinase inhibitor CP-690,550
- (2010) Lalitha Vijayakrishnan et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Influence of the mannose receptor in host immune responses
- (2009) Umut Gazi et al. IMMUNOBIOLOGY
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Cytokine Signaling Modules in Inflammatory Responses
- (2008) John J. O'Shea et al. IMMUNITY
- Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses
- (2008) Frederic Geissmann et al. IMMUNOLOGY AND CELL BIOLOGY
- Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis
- (2008) James D. Lewis et al. INFLAMMATORY BOWEL DISEASES
- Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease
- (2008) Stephan Brackmann et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started